Newsbenzinga
Zymeworks Said To Near $929M Deal For Theravance At $17 Per Share, Bloomberg News Reports
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…